Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Jul;109(4):499-501.
doi: 10.1590/0074-0276130563. Epub 2014 Jul 3.

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

Affiliations
Observational Study

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

Andrea Barbieri Barros et al. Mem Inst Oswaldo Cruz. 2014 Jul.

Abstract

Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.

PubMed Disclaimer

Figures

None
Cumulative probability of the development of herpes zoster during treatment with antimony compounds.

References

    1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. Leishmaniasis worldwide and global estimates of its incidence. e35671PLoS ONE. 2012;7 - PMC - PubMed
    1. Aslamazov EG, Metel’skaia AO, Tumol’skaia NI. Herpes zoster as a result of the toxic effect of antimony compounds on the organism. Med Parazitol (Mosk) 1966;35:600–601. - PubMed
    1. Campbell K. Incidence rates and correlates of risk of herpes zoster, US Armed Forces, 1998-2001. MSMR. 2002;8:2–5.
    1. Chakravarty EF. Viral infection and reactivation in autoimmune disease. Arthritis Rheum. 2008;58:2949–2957. - PubMed
    1. Chulay JD, Bhatt SM, Muigai R, Ho M, Gachihi G, Were JB, Chunge C, Beyceson AD. A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J Infect Dis. 1983;148:148–155. - PubMed

Publication types